Rehmann Capital Advisory »

United Therapeutics Corporation shares owned by Rehmann Capital Advisory

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by Rehmann Capital Advisory from 13F filings

Historical chart of Rehmann Capital Advisory investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by Rehmann Capital Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by Rehmann Capital Advisory

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.4M 3.3k 418.70
2025-06-30 $624k 2.2k 287.35
2025-03-31 $562k 1.8k 308.27
2019-09-30 $3.1k 39 79.74
2019-06-30 $3.0k 39 78.05
2019-03-31 $4.6k 39 117.36
2018-12-31 $4.2k 39 108.90
2018-09-30 $5.0k 39 127.87
2018-06-30 $14k 119 113.15
2018-03-31 $13k 119 109.24
2014-09-30 $207k 1.6k 128.57
2013-12-31 $302k 2.7k 113.07

More positions owned by Rehmann Capital Advisory

Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Core Msci Eafe (IEFA)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Ishares Tr S&p Mc 400vl Etf (IJJ)
Ishares Tr Core S&p Ttl Stk (ITOT)
Spdr Series Trust S&P 400 MDCP GRW (MDYG)
Ishares Tr Msci Usa Min Vol (USMV)
Ishares Tr Core S&p Scp Etf (IJR)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)

View all positions for Rehmann Capital Advisory

Top funds holding United Therapeutics Corporation

BlackRock
Vanguard Group
venBio Select Advisor
Renaissance Technologies
State Street Corporation
Wellington Management Company
Susquehanna International
Geode Capital Management
AQR Capital Management
Darwin Global Management
LSV Asset Management
Assetmark
Invesco
Caption Management
Dimensional Fund Advisors

View all funds holding United Therapeutics Corporation